Osteoporosis Therapeutics Market

• 9.1. Bisphosphonates
• 9.2. Selective Estrogen Inhibitor Modulators (SERM)
• 9.3. Parathyroid Hormone Therapies
• 9.4. Calcitonin
• 9.5. Rank Ligand Inhibitors

• 10.1. Oral
• 10.2. Injectables
• 10.3. Other Routes of Administration

• 11.1. North America
• 11.2. Latin America
• 11.3. Europe
• 11.4. East Asia
• 11.5. South Asia
• 11.6. Oceania
• 11.7. Middle East and Africa (MEA)

• 21.1. Allergan Plc.
• 21.2. Amgen Inc.
• 21.3. Chugai Pharmaceutical
• 21.4. Daiichi Sankyo Co. Ltd.
• 21.5. Egalet Corporation
• 21.6. Eisai Co. Ltd.
• 21.7. Eli Lilly and Company
• 21.8. F. Hoffmann-La Roche Ltd.

Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017 to 2026, By Drug Class

Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Drug Class

Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Route of Administration

Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Region

Table 05: North America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country

Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Drug Class

Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Route of Administration

Table 08: Latin America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country

Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Drug Class

Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Route of Administration

Table 11: Europe Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country

Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Drug Class

Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Route of Administration

Table 14: South Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country

Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Drug Class

Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Route of Administration

Table 17: East Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country

Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Drug Class

Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Route of Administration

Table 20: Oceania Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country

Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Drug Class

Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Route of Administration

Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country

Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Drug Class

Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Route of Administration

Figure 01: Global Market Volume (in 000' Units) Analysis, 2017 to 2021

Figure 02: Global Market Volume Forecast (in 000' Units), 2022 to 2026

Figure 03: Pricing Analysis (US$) Per Product, By Region, 2021

Figure 04: Pricing Analysis (US$) Per Product, By Region, 2021

Figure 05: Global Market Value Analysis (US$ Mn), 2017 to 2021

Figure 06: Global Market Value Forecast (US$ Mn), 2022 to 2026

Figure 07: Global Market Absolute $ Opportunity, 2022 to 2026

Figure 08: Global Market Share Analysis (%), By Drug Class, 2022 to 2026

Figure 09: Global Market Y-o-Y Analysis (%), By Drug Class, 2022 to 2026

Figure 10: Global Market Attractiveness Analysis by Drug Class, 2022 to 2026

Figure 11: Global Market Share Analysis (%), By Route of Administration, 2022 to 2026

Figure 12: Global Market Y-o-Y Analysis (%), By Route of Administration, 2022 to 2026

Figure 13: Global Market Attractiveness Analysis by Route of Administration, 2022 to 2026

Figure 14: Global Market Share Analysis (%), By Region, 2022 to 2026

Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2022 to 2026

Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2026

Figure 17: North America Market Value Share, By Drug Class, 2022 (E)

Figure 18: North America Market Value Share, By Route of Administration, 2022 (E)

Figure 19: North America Market Value Share, By Country, 2022 (E)

Figure 20: North America Market Value Analysis (US$ Mn), 2017 to 2021

Figure 21: North America Market Value Forecast (US$ Mn), 2022 to 2026

Figure 22: North America Market Attractiveness Analysis by Drug Class, 2022 to 2026

Figure 23: North America Market Attractiveness Analysis by Route of Administration, 2022 to 2026

Figure 24: North America Market Attractiveness Analysis by Country, 2022 to 2026

Figure 25: Latin America Market Value Share, By Drug Class, 2022 (E)

Figure 26: Latin America Market Value Share, By Route of Administration, 2022 (E)

Figure 27: Latin America Market Value Share, By Country, 2022 (E)

Figure 28: Latin America Market Value Analysis (US$ Mn), 2017 to 2021

Figure 29: Latin America Market Value Forecast (US$ Mn), 2022 to 2026

Figure 30: Latin America Market Attractiveness Analysis by Drug Class, 2022 to 2026

Figure 31: Latin America Market Attractiveness Analysis by Route of Administration, 2022 to 2026

Figure 32: Latin America Market Attractiveness Analysis by Country, 2022 to 2026

Figure 33: Europe Market Value Share, By Drug Class, 2022 (E)

Figure 34: Europe Market Value Share, By Route of Administration, 2022 (E)

Figure 35: Europe Market Value Share, By Country, 2022 (E)

Figure 36: Europe Market Value Analysis (US$ Mn), 2017 to 2021

Figure 37: Europe Market Value Forecast (US$ Mn), 2022 to 2026

Figure 38: Europe Market Attractiveness Analysis by Drug Class, 2022 to 2026

Figure 39: Europe Market Attractiveness Analysis by Route of Administration, 2022 to 2026

Figure 40: Europe Market Attractiveness Analysis by Country, 2022 to 2026

Figure 41: South Asia Market Value Share, By Drug Class, 2022 (E)

Figure 42: South Asia Market Value Share, By Route of Administration, 2022 (E)

Figure 43: South Asia Market Value Share, By Country, 2022 (E)

Figure 44: South Asia Market Value Analysis (US$ Mn), 2017 to 2021

Figure 45: South Asia Market Value Forecast (US$ Mn), 2022 to 2026

Figure 46: South Asia Market Attractiveness Analysis by Drug Class, 2022 to 2026

Figure 47: South Asia Market Attractiveness Analysis by Route of Administration, 2022 to 2026

Figure 48: South Asia Market Attractiveness Analysis by Country, 2022 to 2026

Figure 49: East Asia Market Value Share, By Drug Class, 2022 (E)

Figure 50: East Asia Market Value Share, By Route of Administration, 2022 (E)

Figure 51: East Asia Market Value Share, By Country, 2022 (E)

Figure 52: East Asia Market Value Analysis (US$ Mn), 2017 to 2021

Figure 53: East Asia Market Value Forecast (US$ Mn), 2022 to 2026

Figure 54: East Asia Market Attractiveness Analysis by Drug Class, 2022 to 2026

Figure 55: East Asia Market Attractiveness Analysis by Route of Administration, 2022 to 2026

Figure 56: East Asia Market Attractiveness Analysis by Country, 2022 to 2026

Figure 57: Oceania Market Value Share, By Drug Class, 2022 (E)

Figure 58: Oceania Market Value Share, By Route of Administration, 2022 (E)

Figure 59: Oceania Market Value Share, By Country, 2022 (E)

Figure 60: Oceania Market Value Analysis (US$ Mn), 2017 to 2021

Figure 61: Oceania Market Value Forecast (US$ Mn), 2022 to 2026

Figure 62: Oceania Market Attractiveness Analysis by Drug Class, 2022 to 2026

Figure 63: Oceania Market Attractiveness Analysis by Route of Administration, 2022 to 2026

Figure 64: Oceania Market Attractiveness Analysis by Country, 2022 to 2026

Figure 65: Middle East and Africa Market Value Share, By Drug Class, 2022 (E)

Figure 66: Middle East and Africa Market Value Share, By Route of Administration, 2022 (E)

Figure 67: Middle East and Africa Market Value Share, By Country, 2022 (E)

Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2017 to 2021

Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2022 to 2026

Figure 70: Middle East and Africa Market Attractiveness Analysis by Drug Class, 2022 to 2026

Figure 71: Middle East and Africa Market Attractiveness Analysis by Route of Administration, 2022 to 2026

Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2022 to 2026

Figure 73: U. S. Market Value Analysis (US$ Mn), 2022 & 2026

Figure 74: U. S. Market Value Share, By Drug Class, 2022 (E)

Figure 75: U. S. Market Value Share, By Route of Administration, 2022 (E)

Figure 76: Canada Market Value Analysis (US$ Mn), 2022 & 2026

Figure 77: Canada Market Value Share, By Drug Class, 2022 (E)

Figure 78: Canada Market Value Share, By Route of Administration, 2022 (E)

Figure 79: Mexico Market Value Analysis (US$ Mn), 2022 & 2026

Figure 80: Mexico Market Value Share, By Drug Class, 2022 (E)

Figure 81: Mexico Market Value Share, By Route of Administration, 2022 (E)

Figure 82: Brazil Market Value Analysis (US$ Mn), 2022 & 2026

Figure 83: Brazil Market Value Share, By Drug Class, 2022 (E)

Figure 84: Brazil Market Value Share, By Route of Administration, 2022 (E)

Figure 85: U. K. Market Value Analysis (US$ Mn), 2022 & 2026

Figure 86: U. K. Market Value Share, By Drug Class, 2022 (E)

Figure 87: U. K. Market Value Share, By Route of Administration, 2022 (E)

Figure 88: Germany Market Value Analysis (US$ Mn), 2022 & 2026

Figure 89: Germany Market Value Share, By Drug Class, 2022 (E)

Figure 90: Germany Market Value Share, By Route of Administration, 2022 (E)

Figure 91: France Market Value Analysis (US$ Mn), 2022 & 2026

Figure 92: France Market Value Share, By Drug Class, 2022 (E)

Figure 93: France Market Value Share, By Route of Administration, 2022 (E)

Figure 94: Italy Market Value Analysis (US$ Mn), 2022 & 2026

Figure 95: Italy Market Value Share, By Drug Class, 2022 (E)

Figure 96: Italy Market Value Share, By Route of Administration, 2022 (E)

Figure 97: Spain Market Value Analysis (US$ Mn), 2022 & 2026

Figure 98: Spain Market Value Share, By Drug Class, 2022 (E)

Figure 99: Spain Market Value Share, By Route of Administration, 2022 (E)

Figure 100: Russia Market Value Analysis (US$ Mn), 2022 & 2026

Figure 101: Russia Market Value Share, By Drug Class, 2022 (E)

Figure 102: Russia Market Value Share, By Route of Administration, 2022 (E)

Figure 103: China Market Value Analysis (US$ Mn), 2022 & 2026

Figure 104: China Market Value Share, By Drug Class, 2022 (E)

Figure 105: China Market Value Share, By Route of Administration, 2022 (E)

Figure 106: Japan Market Value Analysis (US$ Mn), 2022 & 2026

Figure 107: Japan Market Value Share, By Drug Class, 2022 (E)

Figure 108: Japan Market Value Share, By Route of Administration, 2022 (E)

Figure 109: South Korea Market Value Analysis (US$ Mn), 2022 & 2026

Figure 110: South Korea Market Value Share, By Drug Class, 2022 (E)

Figure 111: South Korea Market Value Share, By Route of Administration, 2022 (E)

Figure 112: India Market Value Analysis (US$ Mn), 2022 & 2026

Figure 113: India Market Value Share, By Drug Class, 2022 (E)

Figure 114: India Market Value Share, By Route of Administration, 2022 (E)

Figure 115: ASEAN Market Value Analysis (US$ Mn), 2022 & 2026

Figure 116: ASEAN Market Value Share, By Drug Class, 2022 (E)

Figure 117: ASEAN Market Value Share, By Route of Administration, 2022 (E)

Figure 118: Australia Market Value Analysis (US$ Mn), 2022 & 2026

Figure 119: Australia Market Value Share, By Drug Class, 2022 (E)

Figure 120: Australia Market Value Share, By Route of Administration, 2022 (E)

Figure 121: New Zealand Market Value Analysis (US$ Mn), 2022 & 2026

Figure 122: New Zealand Market Value Share, By Drug Class, 2022 (E)

Figure 123: New Zealand Market Value Share, By Route of Administration, 2022 (E)

Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2022 & 2026

Figure 125: GCC Countries Market Value Share, By Drug Class, 2022 (E)

Figure 126: GCC Countries Market Value Share, By Route of Administration, 2022 (E)

Figure 127: Turkey Market Value Analysis (US$ Mn), 2022 & 2026

Figure 128: Turkey Market Value Share, By Drug Class, 2022 (E)

Figure 129: Turkey Market Value Share, By Route of Administration, 2022 (E)

Figure 130: South Africa Market Value Analysis (US$ Mn), 2022 & 2026

Figure 131: South Africa Market Value Share, By Drug Class, 2022 (E)

Figure 132: South Africa Market Value Share, By Route of Administration, 2022 (E)